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ABSTRACT
Introduction: Reduced cerebral blood fl ow is associated with neurodegenerative disorders and dementia, in 
particular. Experimental evidence has demonstrated the initiating role of chronic cerebral hypoperfusion in 
neuronal damage to the hippocampus, the cerebral cortex, the white matter areas and the visual system. 
Permanent, bilateral occlusion of the common carotid arteries of rats (two vessel occlusion - 2VO) has been 
introduced for the reproduction of chronic cerebral hypoperfusion as it occurs in Alzheimer’s disease and human 
aging. Increased generation of free radicals through lipid peroxidation can damage neuronal cell membrane. 
Markers of lipid peroxidation have been found to be elevated in brain tissues and body fl uids in neurodegen-
erative diseases, including Alzheimer’s disease, Parkinson disease and amyotrophic lateral sclerosis. Materials 
and Methods: Malondialdehyde (MDA), fi nal product of lipid peroxidation, was estimated by thiobarbituric 
acid-reactive substances (TBARS) assay kit at eight weeks after induction of 2VO in the rats and control group. 
Results: Our study revealed a highly signifi cant (p<0.001) increase in the mean MDA concentration (12.296 
± 1.113 μM) in 2VO rats as compared to the control group (5.286 ± 0.363 μM) rats. Conclusion: Therapeutic 
strategies to modulate lipid peroxidation early throughout the course of the disease may be promising in 
slowing or possibly preventing neurodegenerative disorders.
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INTRODUCTION
Neurodegenerative disorders, including Alzheimer’s 
disease (AD), Parkinson’s disease (PD) and Huntington’s
disease are characterized by progressive and 
irreversible loss of neurons from specifi c regions of 
the brain.1 These disorders are not so uncommon and 
present a substantial medical and social problem.1 
Aging is a major risk factor for neurodegenerative 
disorders,2 and reduced cerebral blood fl ow (CBF) 
is associated with aging and dementia.3 A chronic 
reduction in CBF is believed to induce the neurode-
generative processes. Chronic cerebral hypoperfusion 
as it occurs in human aging and Alzheimer’s disease 
can be induced by permanent, bilateral occlusion of 
the common carotid arteries (two vessel occlusion, 
2VO) of rats.4 Experimental evidence has shown 
that chronic cerebral hypoperfusion can initiate the 
neural damage to the hippocampus, the cerebral 
cortex, the white matter areas and the visual 
system.5,6,7,8
However, the CBF pattern in 2VO rats is not perfectly 
identical to that as it occurs in aging or demented 
humans. Following induction of occlusion in 2VO rats, 
the CBF drops sharply and then starts normalizing 
after about three months due to compensatory and 
adaptive mechanisms. However, there is a relatively 
long period of time (eight weeks to 12 weeks), the 
chronic oligemic phase, during which the cerebral 
hypoperfusion in 2VO rats is comparable to that in 
humans.9
Cerebral hypoperfusion-induced neuronal cell death 
can be visualized with hematoxylin-eosin dye. With 
conventional staining procedures no obvious loss of 
neurons was seen during the fi rst week after 2VO
induction.10 At two weeks, six to 29% of the animals 
exhibited hippocampal injury in the CA1 area.11 At 
four weeks, this had increased to 55%10, while at eight 
to 13 weeks, total hippocampal damage was seen in 
67% of the 2VO rats.12  This demonstrates that the 
neurodegeneration in the hippocampus gradually 
increased with time and that the most extensive 
neurodegeneration takes place during the chronic 
phase (eight to 13 weeks) of 2VO-induced cerebral 
hypoperfusion.       
Oxidative stress is widely recognized nowadays as 
an important feature of many neurological disorders
because brain is highly susceptible to lipid 
peroxidation due to its high oxygen utilization, 
low levels of antioxidants, and high levels of 
polyunsaturated fatty acids (the substrate for lipid
peroxidation). Peroxidation of membrane lipids 
can result in numerous effects, including increased 
membrane rigidity, decreased activity of membrane
bound enzymes, altered activity of membrane 
receptors and altered permeability.13,14 There are 
suggestions that oxidative injury plays a role in 
Alzheimer’s disease, Parkinson’s disease, multiple scle-
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rosis, schizophrenia, mitochondrial encephalopathies
and brain injury due to ischemia and reperfusion.15
However, not much is known about the possible role 
of lipid peroxidation-induced oxidative stress in 
the pathogenesis of chronic cerebral hypoperfusion
-induced neurodegeneration in 2VO rats.
The present study was, therefore, designed to evaluate
the lipid peroxidation status during chronic phase of 
cerebral hypoperfusion in 2VO rats by estimating the 
malondialdehyde (MDA) concentrations in the brain 
tissue.
MATERIALS AND METHODS
The present study was conducted on Wistar rats 
of either sex, weighing 200-250 g. The rats were 
obtained from Universiti Sains Malaysia and were 
kept in standard plastic cages. They were maintained 
on ad libitum food and water and were treated in 
accordance with the Guidelines for the Care and Use 
of Laboratory Animals of the National Institute of the 
Health. Every effort was made to minimize suffering 
to the rats. 
After one week of acclimatization, rats were randomly
divided into two groups. Group A (n=7) rats served 
as a control and they were not subjected to 2VO. 
Group B (n=7) rats were subjected to permanent, 
bilateral common carotid arteries occlusion. They were 
anesthetized with intraperitoneal injection of 
ketamine (90 mg/kg) and xylazine (10 mg/kg). After 
making a small midline cervical incision, both common 
carotid arteries were gently isolated and separated 
from the carotid sheath and vagal nerve. They were 
then permanently ligated with sterilized silk suture 
and the incision was stitched and the wound treated 
with betadine solution. The body temperature was 
maintained throughout the surgical procedure and 
recovery period by heat lamps.
Group A and Group B (after 8th week of 2VO) rats were 
sacrifi ced by euthanization with ether. The brain 
was quickly dissected out and rinsed with phosphate 
buffer saline (pH 7.4) to remove any red blood 
cells and clots. It was weighed and sonicated with 
1 ml/100mg of cold RIPA buffer containing 1 mM 
EDTA. Samples were centrifuged at 1600 revolutions 
per minute for 10 min at 4ºC for thiobarbituric acid-
reactive substances (TBARS). Supernatant was 
collected and stored at -80ºC.
Determination of Lipid peroxidation 
TBARS measure the concentration of MDA, an end 
product of the oxidation and decomposition of 
polyunsaturated fatty acids containing three or 
more double bonds. Although this method has been 
criticized for its lack of specifi city, sensitivity, and 
reproducibility, it is still one of the easiest and most 
frequently used methods.   
MDA levels were estimated by TBARS Assay Kit
(Cay man Chemicals, USA) strictly according to the
instructions laid down in the catalogue. The 
absorbance was read at 530-540 nm using a multi
 detection microplate reader Infi nite M200. The average
absorbance of each standard and sample was 
calculated.  The absorbance value of the standard 
was subtracted from its value and from both standard 
and sample values of absorbance. The corrected 
absorbance values of each standard were plotted as a 
function of MDA concentration. The values of MDA for 
each sample were calculated from the standard curve.
 MDA (μM) = {Corrected absorbance – y 
 intercept} / slope
Statistical Analysis
The data were analyzed using Predictive Analytics
Software (PASW version 18.0) and are presented 
here as mean ± SEM values. Comparison between the 
groups was done by independent t-test (Gaussian).
Differences were designated as signifi cant when 
p <0.05 at 95% confi dence interval.
RESULTS
The mean MDA level in the 2VO group (12.296 ± 1.113 
μM) was found to be highly signifi cant (p<0.001) as 
compared to the control group (5.286 ± 0.363 μM) as 
shown in Fig 1.
DISCUSSION AND CONCLUSION
Oxidative stress has long been linked to the neuronal 
cell death that is associated with neurodegenerative 
disorders. Numerous studies have reported increased 
lipid peroxidation in the brain of patients with 
Alzheimer’s disease compared with age-matched 
controls.16,17,18 As lipid peroxidation can be measured, 
not only in brain tissue but also in body fl uids, it might 
be used as a useful marker of disease progression and 
as a monitor of therapeutic effi cacy. 
Figure 1. Mean MDA concentrations in the 2VO and 
control groups.*p<0.001
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death in chronic cerebral hypoperfusion begins with 
neuronal ATP depletion due to reduced CBF and
consequent hypoxia and hypoglycemia. In ischemic 
brain injury or stroke, the loss of ATP is followed by 
generation of reactive oxygen species (ROS) lethal 
to neurons at high concentration. The ROS in turn
initiate lipid peroxidation; generating lipid peroxides 
that are degraded to reactive aldehyde products 
such as MDA.19 However, increased lipid peroxidation 
and a decreased capacity of the antioxidant systems 
have primarily been associated with reperfusion after 
ischemia, which is very gradual in permanent, chronic 
2VO due to cerebral blood fl ow compensation.20 
The concentration of MDA, indicative of lipid 
peroxidation, was signifi cantly increased (p<0.001) 
after eight weeks of 2VO in our study, as is typically 
seen in ischemic brain injury. Similarly, increase in 
MDA level was reported by Aytac et al. after 10 days 
of 2VO in rats.21 However, Institoris et al. could not 
fi nd any signifi cant change in the levels of superoxide 
dismutase suggesting that the degree of oxidative
stress is not remarkable in this model or other 
antioxidant mechanisms are induced against oxidative 
agents.22   
Our preliminary data require confi rmation, but it is 
currently considered that 2VO produces a permanent 
ischemic/oligemic condition suffi cient enough to 
initiate and maintain oxidative stress, which could be 
the reason for the persistent and progressive neuronal 
damage.
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